Apply Now! Discovery Stage Funding + Webinar on April 7

The California Institute for Regenerative Medicine (CIRM) is pleased to announce the opening of our next round of Quest Awards (DISC2) for discovery stage research. The purpose of the Quest Awards is to promote discovery of promising new stem cell-based and/or gene therapy technologies that could be translated to enable broad use and ultimately, improve patient care. The expected … Continue reading Apply Now! Discovery Stage Funding + Webinar on April 7

Reminder! Apply now for discovery stage stem cell and gene therapy research funding

The California Institute for Regenerative Medicine (CIRM) is seeking applications for its next round of Quest Awards (DISC2) for discovery stage research. Applications are due August 2nd, 2022, at 2:00 PM PDT. Please visit the CIRM website for full details.   The purpose of the Quest Awards is to promote the discovery of promising new stem cell-based or gene therapy … Continue reading Reminder! Apply now for discovery stage stem cell and gene therapy research funding

CIRM Board Approves Two New Discovery Research Projects for COVID-19

Dr. Karen Christman (left) and Dr. Lili Yang (right) This past Friday the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new discovery research project as part of the $5 million in emergency funding for COVID-19 related projects.  This brings the number of COVID-19 projects CIRM is supporting to 17, including three clinical trials. … Continue reading CIRM Board Approves Two New Discovery Research Projects for COVID-19

Research Targeting Prostate Cancer Gets Almost $4 Million Support from CIRM

A program hoping to supercharge a patient’s own immune system cells to attack and kill a treatment resistant form of prostate cancer was today awarded $3.99 million by the governing Board of the California Institute for Regenerative Medicine (CIRM) In the U.S., prostate cancer is the second most common cause of cancer deaths in men.  … Continue reading Research Targeting Prostate Cancer Gets Almost $4 Million Support from CIRM